Literature DB >> 12364805

Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations.

Amar Bir Singh Sidhu1, Dominik Verdier-Pinard, David A Fidock.   

Abstract

Plasmodium falciparum chloroquine resistance is a major cause of worldwide increases in malaria mortality and morbidity. Recent laboratory and clinical studies have associated chloroquine resistance with point mutations in the gene pfcrt. However, direct proof of a causal relationship has remained elusive and most models have posited a multigenic basis of resistance. Here, we provide conclusive evidence that mutant haplotypes of the pfcrt gene product of Asian, African, or South American origin confer chloroquine resistance with characteristic verapamil reversibility and reduced chloroquine accumulation. pfcrt mutations increased susceptibility to artemisinin and quinine and minimally affected amodiaquine activity; hence, these antimalarials warrant further investigation as agents to control chloroquine-resistant falciparum malaria.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12364805      PMCID: PMC2954758          DOI: 10.1126/science.1074045

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  40 in total

1.  Multi-drug resistant falciparum malaria in Cameroon in 1987-1988. I. Stable figures of prevalence of chloroquine- and quinine-resistant isolates in the original foci.

Authors:  P Brasseur; J Kouamouo; R Moyou-Somo; P Druilhe
Journal:  Am J Trop Med Hyg       Date:  1992-01       Impact factor: 2.345

2.  Physicochemical properties correlated with drug resistance and the reversal of drug resistance in Plasmodium falciparum.

Authors:  P G Bray; S R Hawley; M Mungthin; S A Ward
Journal:  Mol Pharmacol       Date:  1996-12       Impact factor: 4.436

Review 3.  Systematic review of amodiaquine treatment in uncomplicated malaria.

Authors:  P Olliaro; C Nevill; J LeBras; P Ringwald; P Mussano; P Garner; P Brasseur
Journal:  Lancet       Date:  1996-11-02       Impact factor: 79.321

4.  Analysis of pfmdr1 and drug susceptibility in fresh isolates of Plasmodium falciparum from subsaharan Africa.

Authors:  L K Basco; J Le Bras; Z Rhoades; C M Wilson
Journal:  Mol Biochem Parasitol       Date:  1995-11       Impact factor: 1.759

5.  Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil.

Authors:  D A Fidock; T E Wellems
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

6.  Aminoquinolines that circumvent resistance in Plasmodium falciparum in vitro.

Authors:  D De; F M Krogstad; F B Cogswell; D J Krogstad
Journal:  Am J Trop Med Hyg       Date:  1996-12       Impact factor: 2.345

7.  4-aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum.

Authors:  R G Ridley; W Hofheinz; H Matile; C Jaquet; A Dorn; R Masciadri; S Jolidon; W F Richter; A Guenzi; M A Girometta; H Urwyler; W Huber; S Thaithong; W Peters
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

8.  Energy dependence of chloroquine accumulation and chloroquine efflux in Plasmodium falciparum.

Authors:  D J Krogstad; I Y Gluzman; B L Herwaldt; P H Schlesinger; T E Wellems
Journal:  Biochem Pharmacol       Date:  1992-01-09       Impact factor: 5.858

9.  In vitro activity of monodesethylamodiaquine and amopyroquine against African isolates and clones of Plasmodium falciparum.

Authors:  L K Basco; J Le Bras
Journal:  Am J Trop Med Hyg       Date:  1993-01       Impact factor: 2.345

10.  Plasmodium falciparum: detection of P-glycoprotein in chloroquine-susceptible and chloroquine-resistant clones and isolates.

Authors:  G Cremer; L K Basco; J Le Bras; D Camus; C Slomianny
Journal:  Exp Parasitol       Date:  1995-08       Impact factor: 2.011

View more
  260 in total

1.  Lead optimization of aryl and aralkyl amine-based triazolopyrimidine inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity in mice.

Authors:  Ramesh Gujjar; Farah El Mazouni; Karen L White; John White; Sharon Creason; David M Shackleford; Xiaoyi Deng; William N Charman; Ian Bathurst; Jeremy Burrows; David M Floyd; David Matthews; Frederick S Buckner; Susan A Charman; Margaret A Phillips; Pradipsinh K Rathod
Journal:  J Med Chem       Date:  2011-05-12       Impact factor: 7.446

2.  pfcrt Allelic types with two novel amino acid mutations in chloroquine-resistant Plasmodium falciparum isolates from the Philippines.

Authors:  Nanhua Chen; Dennis E Kyle; Cielo Pasay; Elizabeth V Fowler; Joanne Baker; Jennifer M Peters; Qin Cheng
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

Review 3.  History, dynamics, and public health importance of malaria parasite resistance.

Authors:  Ambrose O Talisuna; Peter Bloland; Umberto D'Alessandro
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

4.  Evolutionary dynamics of escape from biomedical intervention.

Authors:  Yoh Iwasa; Franziska Michor; Martin A Nowak
Journal:  Proc Biol Sci       Date:  2003-12-22       Impact factor: 5.349

Review 5.  Therapy of falciparum malaria in sub-saharan Africa: from molecule to policy.

Authors:  Peter Winstanley; Stephen Ward; Robert Snow; Alasdair Breckenridge
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

6.  Drug susceptibility and genetic evaluation of Plasmodium falciparum isolates obtained in four distinct geographical regions of Kenya.

Authors:  Abigael Mbaisi; Pamela Liyala; Fredrick Eyase; Rachel Achilla; Hosea Akala; Julia Wangui; Josphat Mwangi; Finnley Osuna; Uzma Alam; Bonnie L Smoak; Jon M Davis; Dennis E Kyle; Rodney L Coldren; Carl Mason; Norman C Waters
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

7.  Discordant temporal evolution of Pfcrt and Pfmdr1 genotypes and Plasmodium falciparum in vitro drug susceptibility to 4-aminoquinolines after drug policy change in French Guiana.

Authors:  Eric Legrand; Joséphine Yrinesi; Marie-Thérèse Ekala; Julie Péneau; Béatrice Volney; Franck Berger; Christiane Bouchier; Stéphane Bertani; Lise Musset; Jean-Baptiste Meynard; Odile Mercereau-Puijalon
Journal:  Antimicrob Agents Chemother       Date:  2012-01-09       Impact factor: 5.191

Review 8.  How can we identify parasite genes that underlie antimalarial drug resistance?

Authors:  Tim Anderson; Standwell Nkhoma; Andrea Ecker; David Fidock
Journal:  Pharmacogenomics       Date:  2011-01       Impact factor: 2.533

9.  Optimization of propafenone analogues as antimalarial leads.

Authors:  David J Lowes; W Armand Guiguemde; Michele C Connelly; Fangyi Zhu; Martina S Sigal; Julie A Clark; Andrew S Lemoff; Joseph L Derisi; Emily B Wilson; R Kiplin Guy
Journal:  J Med Chem       Date:  2011-10-10       Impact factor: 7.446

10.  A high-content phenotypic screen reveals the disruptive potency of quinacrine and 3',4'-dichlorobenzamil on the digestive vacuole of Plasmodium falciparum.

Authors:  Yan Quan Lee; Amanda S P Goh; Jun Hong Ch'ng; François H Nosten; Peter Rainer Preiser; Shazib Pervaiz; Sanjiv Kumar Yadav; Kevin S W Tan
Journal:  Antimicrob Agents Chemother       Date:  2013-11-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.